Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: J Clin Pharmacol. 2013 May 17;53(7):773–778. doi: 10.1002/jcph.98

Table 2.

Adjusted hazard ratios for Prostate Cancer occurrence, double-robust Inverse Probability treatment weighted survival analysis

Variables Hazard Ratio

Angiotensin Receptor Blocker 0.91 (0.84 to 1, p-value 0.049)

Age group (Reference '>=70')

  65 to 70 years 1.03 (0.97 to 1.1, p-value 0.3974)

  60 to 65 1.51 (1.42 to 1.61, p-value <.0001)

  < 60 1.03 (0.97 to 1.1, p-value 0.3974)

Race (reference 'White' or European American)

  African American 2.44 (2.32 to 2.56, p-value <.0001)

  Hawaiian or Pacific Islander 0.86 (0.59 to 1.26, p-value 0.4397)

  Mixed European- and African- American race 1.79 (1.58 to 2.03, p-value <.0001)

  Mixed other races 1.09 (0.81 to 1.46, p-value 0.5655)

  Other races 1.09 (0.81 to 1.46, p-value 0.5655)

Hispanic ethnicity 1.19 (1.09 to 1.31, p-value 0.0001)

Smoker (reference 'Never')

  Current 1.69 (1.38 to 2.06, p-value <.0001)

  Former 1.58 (1.29 to 1.93, p-value <.0001)

Body Mass Index 0.99 (0.98 to 0.99, p-value <.0001)

Diabetes Mellitus 0.99 (0.94 to 1.05, p-value 0.8303)